Fax: (650) 723-5795
Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma
Article first published online: 19 DEC 2003
Copyright © 2004 American Cancer Society
Volume 100, Issue 3, pages 479–489, 1 February 2004
How to Cite
Hartman, A.-R., Daniel, B. L., Kurian, A. W., Mills, M. A., Nowels, K. W., Dirbas, F. M., Kingham, K. E., Chun, N. M., Herfkens, R. J., Ford, J. M. and Plevritis, S. K. (2004), Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma. Cancer, 100: 479–489. doi: 10.1002/cncr.11926
Fax: (650) 723-5795
- Issue published online: 20 JAN 2004
- Article first published online: 19 DEC 2003
- Manuscript Accepted: 30 OCT 2003
- Manuscript Revised: 23 OCT 2003
- Manuscript Received: 12 AUG 2003
- California Breast Cancer Research Foundation
- California Cancer Research Program
- V Foundation
- National Institutes of Health. Grant Number: R01 CA66785
- breast carcinoma;
- magnetic resonance imaging;
- ductal lavage;
- cancer genetics
Intensive screening is an alternative to prophylactic mastectomy in women at high risk for developing breast carcinoma. The current article reports preliminary results from a screening protocol using high-quality magnetic resonance imaging (MRI), ductal lavage (DL), clinical breast examination, and mammography to identify early malignancy and high-risk lesions in women at increased genetic risk of breast carcinoma.
Women with inherited BRCA1 or BRCA2 mutations or women with a > 10% risk of developing breast carcinoma at 10 years, as estimated by the Claus model, were eligible. Patients were accrued from September 2001 to May 2003. Enrolled patients underwent biannual clinical breast examinations and annual mammography, breast MRI, and DL.
Forty-one women underwent an initial screen. Fifteen of 41 enrolled women (36.6%) either had undergone previous bilateral oophorectomy and/or were on tamoxifen at the time of the initial screen. One patient who was a BRCA1 carrier had high-grade ductal carcinoma in situ (DCIS) that was screen detected by MRI but that was missed on mammography. High-risk lesions that were screen detected by MRI in three women included radial scars and atypical lobular hyperplasia. DL detected seven women with cellular atypia, including one woman who had a normal MRI and mammogram.
Breast MRI identified high-grade DCIS and high-risk lesions that were missed by mammography. DL detected cytologic atypia in a high-risk cohort. A larger screening trial is needed to determine which subgroups of high-risk women will benefit and whether the identification of malignant and high-risk lesions at an early stage will impact breast carcinoma incidence and mortality. Cancer 2004. © 2004 American Cancer Society.